
Tenet Healthcare Jumps 46% YTD & Trades Cheap: Should You Buy Now?
THC's 46% YTD surge, upgraded outlook, and discounted valuation highlight its strong growth potential.

Tenet Healthcare Continues To Win In Q2, But Medicaid Cuts May Threaten Growth Beyond 2026
Tenet Healthcare remains a buy, consistently beating earnings and raising guidance, even as the healthcare sector faces broad pressure from looming Medicaid cuts. Ambulatory segment growth is key, ...

Tenet Healthcare Corporation (THC) Q2 2025 Earnings Call Transcript
Tenet Healthcare Corporation (NYSE:THC ) Q2 2025 Earnings Conference Call July 22, 2025 10:00 AM ET Company Participants William McDowell - Vice President of Investor Relations Saumya Sutaria - Cha...

Tenet Beats Q2 Earnings on Strong Patient Volumes, Hikes '25 EPS View
THC's Q2 earnings benefit on the back of strong volumes, facility buyouts, higher acuity and favorable payer mix. It currently expects 2025 adjusted EPS within $15.55-$16.21, up from the earlier vi...

Insights Into Tenet (THC) Q2: Wall Street Projections for Key Metrics
Get a deeper insight into the potential performance of Tenet (THC) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some o...

Will Tenet (THC) Beat Estimates Again in Its Next Earnings Report?
Tenet (THC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Tenet Healthcare (THC) Rises Higher Than Market: Key Facts
The latest trading day saw Tenet Healthcare (THC) settling at $171.52, representing a +1.42% change from its previous close.

Tenet Healthcare (THC) Stock Drops Despite Market Gains: Important Facts to Note
Tenet Healthcare (THC) concluded the recent trading session at $156.56, signifying a -5.79% move from its prior day's close.

Tenet Healthcare (THC) is a Top-Ranked Momentum Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Tenet Healthcare (THC) is a Top-Ranked Growth Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why Fast-paced Mover Tenet (THC) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Tenet (THC) could be a great choice. It is one of the several stocks that passed ...

Why Tenet Healthcare (THC) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Tenet Healthcare Corporation (THC) Q1 2025 Earnings Call Transcript
Tenet Healthcare Corporation (NYSE:THC ) Q1 2025 Earnings Conference Call April 29, 2025 10:00 AM ET Company Participants William McDowell - Vice President-Investor Relations Saum Sutaria - Chairma...

Tenet Healthcare (THC) Surpasses Q1 Earnings and Revenue Estimates
Tenet Healthcare (THC) came out with quarterly earnings of $4.36 per share, beating the Zacks Consensus Estimate of $3.11 per share. This compares to earnings of $3.22 per share a year ago.

Tenet Reports Strong First Quarter 2025 Results
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended March 31, 2025. "We had an excellent start to the year driven by strong s...
Related Companies